NUVB · Nuvation Bio Inc
United States · RS rating 32 · As of 2026-11-03
| Price | 4.69 USD |
|---|---|
| 1-day change | +2.2% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 44 / 24 / 43 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 44 / 13 / 50 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +31.2% |
| Sales growth Q/Q | +219.1% |
| Distance from 52-week high | +50.8% |
| Market cap (USD) | $1.8B |